Cohance Lifesciences Limited
COHANCE
Rankning i aktier
#6353
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Aktiekurs
$5.09
Marknadsvärde
$1.95B
Förändring (1 dag)
0.79%
Förändring (1 år)
-57.07%
Land
IN
Handel Cohance Lifesciences Limited (COHANCE)
Kategori
Healthcare
Historik för aktiesplit för Cohance Lifesciences Limited (COHANCE)
Aktien Cohance Lifesciences Limited (symbol: COHANCE) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 21, 2026.
En COHANCE-aktie köpt före Oct 21, 2026 motsvarar nu 0 COHANCE-aktier.
Den senaste spliten skedde den Oct 21, 2026.
En COHANCE-aktie köpt före Oct 21, 2026 motsvarar nu 0 COHANCE-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| Inte tillräckligt med data för de angivna datumen. | |||
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
